TABLE 2.
Scaffold type | Percent viability compared to monolayer growth
|
|
---|---|---|
Time point
| ||
7 days | 14 days | |
0.0 mg(Ag) g−1 50:50 PLCL scaffold | 124.5 ± 0.5 | 223.1 ± 1.4 |
0.1 mg(Ag) g−1 50:50 PLCL scaffold | 112.6 ± 0.4 | 213.9 ± 2.7 |
0.5 mg(Ag) g−1 50:50 PLCL scaffold | 98.3 ± 1.8 | 150.2 ± 5.2 |
1.0 mg(Ag) g−1 50:50 PLCL scaffold | 75.9 ± 2.4 | 102.0 ± 1.1 |
All data is expressed as mean ± standard error of the mean. Two-way ANOVA with post hoc analysis revealed significant differences between each scaffold (p<0.05) for both time points.